Skip to main content
SpringerLink
Log in

Prevalence of Helicobacter pylori Seropositivity Among Patients Undergoing Bariatric Surgery: A Preliminary Study

  • Published:
World Journal of Surgery Aims and scope Submit manuscript

Abstract

Background

The objective of this study was to compare the prevalence of Helicobacter pylori (HP) seropositivity in patients undergoing bariatric surgery with that of the general population.

Methods

H. pylori serologies, tested by ELISA, were collected on 240 morbidly obese patients seen at the Cleveland Clinic Florida and on 2444 randomly selected patients seen at the Cleveland Clinic Health System from 2003–2005.

Results

H. pylori prevalence was 61.3% in the bariatric surgery group versus 48.2% in the general population control group (p < 0.001). Bariatric patients had a 1.7-fold increased likelihood of having HP when compared with controls (95% CI = 1.3–2.2). Age over 35 years was an independent risk factor for HP seropositivity (p < 0.01) in both the bariatric and control groups. There was no association found between body mass index and seropositivity within the bariatric group. There was no significant association between seropositivity and gender (p = 0.776). However, there was a significant association between seropositivity and race (p < 0.01). African-Americans had four times more (OR = 4.05) probability of having HP seropositivity than Caucasians (p < 0.01). Hispanics had almost three times (OR = 2.6) more probability of having HP seropositivity than Caucasians (p < 0.01).

Conclusion

The prevalence of HP seropositivity among bariatric patients is significantly higher than the general population control group.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  1. National Center for Health Statistics NHANES IV Report. http://www.cdc.gov/nchs/nhanes.htm

  2. Flegal KM, Carroll MD, Ogden CL et al (2002) Prevalence and trends in obesity among US adults, 1999–2000. JAMA 288:1723–1727

    Article  PubMed  Google Scholar 

  3. Buchwald H, Avidor Y, Braunwald E et al (2004) Bariatric surgery: A systematic review and meta-analysis. JAMA 292(14):1724–1737

    Article  PubMed  CAS  Google Scholar 

  4. Marshall BJ, Windsor HM (2005) The relation of Helicobacter pylori to gastric adenocarcinoma and lymphoma: pathophysiology, epidemiology, screening, clinical presentation, treatment, and prevention. Med Clin North Am 89:313–344

    Article  PubMed  Google Scholar 

  5. International Agency for Research on Cancer (1994) Schistosomes, liver flukes and Helicobacter pylori. IARC Working Group on the Evaluation of Carcinogenic Risks to Humans. Lyon, 7–14 June 1994. IARC Monogr Eval Carcinog Risks Hum 61:177–241

    Google Scholar 

  6. Ramaswamy A, Lin E, Ramshaw BJ et al (2004) Early effects of Helicobacter pylori infection in patients undergoing bariatric surgery. Arch Surg 139:1094–1096

    Article  PubMed  Google Scholar 

  7. Schirmer B, Erenoglu C, Miller A (2002) Flexible endoscopy in the management of patient undergoing Roux-en-Y gastric bypass. Obes Surg 12:634–638

    Article  PubMed  Google Scholar 

  8. Papasavas PK, Gagné DJ, Donnelly PE et al (2008) Prevalence of Helicobacter pylori infection and value of preoperative testing and treatment in patients undergoing laparoscopic Roux-en-Y gastric bypass. Surg Obes Relat Dis 4(3):383–388

    Article  PubMed  Google Scholar 

  9. Renshaw AA, Rabaza JR, Gonzalez AM et al (2001) Helicobacter pylori infection in patients undergoing gastric bypass surgery for morbid obesity. Obes Surg 11(3):281–283

    Article  PubMed  CAS  Google Scholar 

  10. Fontana L, Eagon JC, Colonna M et al (2007) Impaired mononuclear cell immune function in extreme obesity is corrected by weight loss. Rejuvenation Res 10(1):41–46

    Article  PubMed  Google Scholar 

  11. O’Rourke RW, Kay T, Lyle EA et al (2006) Alterations in peripheral blood lymphocyte cytokine expression in obesity. Clin Exp Immunol 146(1):39–46

    Article  PubMed  CAS  Google Scholar 

  12. Amar S, Zhou Q, Shaik-Dasthagirisaheb Y et al (2007) Diet-induced obesity in mice causes changes in immune responses and bone loss manifested by bacterial challenge. Proc Natl Acad Sci U S A 104(51):20466–20471

    Article  PubMed  CAS  Google Scholar 

  13. Smith AG, Sheridan PA, Harp JB et al (2007) Diet-induced obese mice have increased mortality and altered immune responses when infected with influenza virus. J Nutr 137:1236–1243

    PubMed  CAS  Google Scholar 

  14. Wu MS, Lee WJ, Wang HH et al (2005) A case-control study of association of Helicobacter pylori infection with morbid obesity in Taiwan. Arch Intern Med 165(13):1552–1555

    Article  PubMed  Google Scholar 

  15. Kuipers EJ, Klinkenberg-Knol EC, Vandenbroucke-Grauls CM et al (1997) Role of Helicobacter pylori in the pathogenesis of atrophic gastritis. Scand J Gastroenterol 223:28–34

    CAS  Google Scholar 

  16. Ohkuma K, Okada M, Murayama H et al (2000) Association of Helicobacter pylori infection with atrophic gastritis and intestinal metaplasia. J Gastroenterol Hepatol 15:1105–1112

    Article  PubMed  CAS  Google Scholar 

  17. Asaka M, Sugiyama T, Nobuta A et al (2001) Atrophic gastritis and intestinal metaplasia in Japan: results of a large multicenter study. Helicobacter 6:294–299

    Article  PubMed  CAS  Google Scholar 

  18. Malfertheiner P, Megraud F, O’Morain C et al (2007) Current concepts in the management of Helicobacter pylori infection: the Maastricht III Consensus Report. Gut 56(6):772–781

    Article  PubMed  CAS  Google Scholar 

  19. Safatle-Ribeiro AV, Kuga R, Iriya K, Ribeiro et al (2007) What to expect in the excluded stomach mucosa after vertical banded Roux-en-Y gastric bypass for morbid obesity. J Gastrointest Surg 11(2):133–137

    Article  PubMed  Google Scholar 

  20. Kihira K, Satoh K, Saifuku K et al (1996) Endoscopic topical therapy for the treatment of Helicobacter pylori infection. J Gastroenterol 31(Suppl 9):66–68

    PubMed  Google Scholar 

  21. Satoh K (1996) Treatment of Helicobacter pylori infection by topical administration of antimicrobial agents. Scand J Gastroenterol Suppl 214:56; discussion 57–60

    Article  PubMed  CAS  Google Scholar 

  22. Nwokolo CU, Mistry P, Pounder RE (1990) The absorption of bismuth and salicylate from oral doses of Pepto-Bismol (bismuth salicylate). Aliment Pharmacol Ther 4:163–169

    Article  PubMed  CAS  Google Scholar 

  23. Whitehead MW, Phillips RH, Sieniawska CE et al (2000) Double-blind comparison of absorbable colloidal bismuth subcitrate and nonabsorbable bismuth subnitrate in the eradication of Helicobacter pylori and the relief of nonulcer dyspepsia. Helicobacter 5:169–175

    Article  PubMed  CAS  Google Scholar 

  24. Moshkowitz M, Konikoff FM, Peled Y et al (1995) High Helicobacter pylori numbers are associated with low eradication rate after triple therapy. Gut 36:845–847

    Article  PubMed  CAS  Google Scholar 

  25. Sheu BS, Yang HB, Su IJ et al (1996) Bacterial density of Helicobacter pylori predicts the success of triple therapy in bleeding duodenal ulcer. Gastrointest Endosc 44:683–688

    Article  PubMed  CAS  Google Scholar 

  26. Megraud F, Brassens Rabbe MP, Denis F et al (1989) Seroepidemiology of Campylobacter pylori infection in various populations. J Clin Microbiol 27:1870–1873

    PubMed  CAS  Google Scholar 

  27. Woodward M, Morrison C, McColl K (2000) An investigation into factors associated with Helicobacter pylori infection. J Clin Epidemiol 53:175–181

    Article  PubMed  CAS  Google Scholar 

  28. Go MF (2002) Review article: natural history and epidemiology of Helicobacter pylori infection. Aliment Pharmacol Ther 16(Suppl 1):3–15

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Gastroenterology, Cleveland Clinic Florida, 2950 Cleveland Clinic Blvd, Weston, Florida, 33331, USA

    Tolga Erim

  2. Medicine & Biochemistry, University of Puerto Rico Comprehensive Cancer Center, San Juan, Puerto Rico

    Marcia R. Cruz-Correa

  3. Division of Minimally Invasive and Bariatric Surgery, The Bariatric Institute, Cleveland Clinic Florida, 2950 Cleveland Clinic Blvd, Weston, Florida, 33331, USA

    Samuel Szomstein & Raul Rosenthal

  4. Health Services Administration Master Program, Barry University, Miami, FL, USA

    Evelio Velis

Authors
  1. Tolga Erim
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Marcia R. Cruz-Correa
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Samuel Szomstein
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Evelio Velis
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Raul Rosenthal
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Raul Rosenthal.

Additional information

Podium presentation at the annual meeting of the American Society of Bariatric Surgery, San Francisco, California, June 26–July 1, 2006.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Erim, T., Cruz-Correa, M.R., Szomstein, S. et al. Prevalence of Helicobacter pylori Seropositivity Among Patients Undergoing Bariatric Surgery: A Preliminary Study. World J Surg 32, 2021–2025 (2008). https://doi.org/10.1007/s00268-008-9608-7

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00268-008-9608-7

Keywords

Search

Navigation